Documento de consenso sobre el tratamiento con infusión subcutánea continua de insulina en el medio hospitalario

Avances en Diabetología Pub Date : 2015-05-01 DOI:10.1016/j.avdiab.2015.02.005

Federico Vázquez , Raquel Barrio , Maria Jose Goñi , Gonzalo Díaz-Soto , Inmaculada Simón Muela , Cintia González Blanco , en representación del Grupo de Nuevas Tecnologías de la Sociedad Española de Diabetes (SED)

{"title":"Documento de consenso sobre el tratamiento con infusión subcutánea continua de insulina en el medio hospitalario","authors":"Federico Vázquez , Raquel Barrio , Maria Jose Goñi , Gonzalo Díaz-Soto , Inmaculada Simón Muela , Cintia González Blanco , en representación del Grupo de Nuevas Tecnologías de la Sociedad Española de Diabetes (SED)","doi":"10.1016/j.avdiab.2015.02.005","DOIUrl":null,"url":null,"abstract":"<div><p>There is an increasing number of people with type1 diabetes treated with continuous subcutaneous insulin infusion therapy (CSII) in Spain, but there are no national guidelines on how to manage insulin pump therapy in the hospital setting. The Group on New Technologies in Diabetes of the Spanish Diabetes Society has reviewed the literature and several international guidelines, and proposes a consensus document on the management of insulin pump therapy for inpatients. The document contains recommendations on indications, contraindications and the requirements needed to maintaining CSII therapy. This review provides a guide for the management of CSII patients in special settings such as the emergency room, surgery, delivery, and for pediatric patients. Finally, the group proposes a set of documents needed to establish a CSII policy in the hospital. In conclusion, CSII therapy can safely be used in the hospital in selected patients after the implementation of a standardized protocol.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"31 3","pages":"Pages 81-88"},"PeriodicalIF":0.0000,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2015.02.005","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Avances en Diabetología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S113432301500054X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

There is an increasing number of people with type 1 diabetes treated with continuous subcutaneous insulin infusion therapy (CSII) in Spain, but there are no national guidelines on how to manage insulin pump therapy in the hospital setting. The Group on New Technologies in Diabetes of the Spanish Diabetes Society has reviewed the literature and several international guidelines, and proposes a consensus document on the management of insulin pump therapy for inpatients. The document contains recommendations on indications, contraindications and the requirements needed to maintaining CSII therapy. This review provides a guide for the management of CSII patients in special settings such as the emergency room, surgery, delivery, and for pediatric patients. Finally, the group proposes a set of documents needed to establish a CSII policy in the hospital. In conclusion, CSII therapy can safely be used in the hospital in selected patients after the implementation of a standardized protocol.

查看原文本刊更多论文

关于医院环境中持续皮下胰岛素输注治疗的共识文件

在西班牙，越来越多的1型糖尿病患者接受持续皮下胰岛素输注治疗(CSII)，但没有关于如何在医院环境中管理胰岛素泵治疗的国家指南。西班牙糖尿病学会糖尿病新技术小组审查了文献和一些国际指南，并提出了一份关于住院患者胰岛素泵治疗管理的共识文件。该文件包含关于适应症、禁忌症和维持CSII治疗所需要求的建议。本综述为特殊情况下CSII患者的管理提供了指南，如急诊室、外科、分娩和儿科患者。最后，小组提出了一套在医院建立CSII政策所需的文件。综上所述，在实施标准化方案后，CSII疗法可以在选定的患者中安全地在医院使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Avances en Diabetología

自引率

0.00%

发文量